Recent updates on GLP-1 agonists: Current advancements & challenges-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Recent updates on GLP-1 agonists: Current advancements & challenges

Published:2018-12 Issue: Volume:108 Page:952-962
ISSN:0753-3322
Container-title:Biomedicine & Pharmacotherapy
language:en
Short-container-title:Biomedicine & Pharmacotherapy

Author:

Sharma Dilip,Verma Suril,Vaidya Shivani,Kalia Kiran,Tiwari Vinod

Funder

Department of Pharmaceuticals, Ministry of Chemical and Fertilizers, Govt of India

National Institute of Pharmaceutical Education and Research (NIPER) Ahmedabad, Gandhinagar, Gujarat, India

Publisher

Elsevier BV

Subject

Pharmacology,General Medicine

Reference99 articles.

1. Clinical inertia in the management of type 2 diabetes mellitus: a focused literature review;Khunti;Br. J. Diabetes,2015

2. Diagnosis and classification of diabetes mellitus;A.D. Association;Diabetes Care,2012

3. Plasma insulin response to oral and intravenous glucose administration 1;Elrick;J. Clin. Endocrinol. Metab.,1964

4. GLP‐1 receptor activated insulin secretion from pancreatic β‐cells: mechanism and glucose dependence;Meloni;Diabetes Obes. Metab.,2013

5. Biology of incretins: GLP-1 and GIP;Baggio;Gastroenterology,2007

Cited by 183 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Tissue-specific activation of insulin signaling as a potential target for obesity-related metabolic disorders;Pharmacology & Therapeutics;2024-10

2. The role of glucagon-like peptide-1 receptor agonists (GLP1-RAs) in the management of the hypertensive patient with metabolic syndrome: a position paper from the Korean society of hypertension;Clinical Hypertension;2024-09-01

3. Daphnetin modulates GLP-1R to alleviate cognitive dysfunction in diabetes: implications for inflammation and oxidative stress;Frontiers in Pharmacology;2024-08-27

4. Mechanistic Insights into Di-2-ethylhexyl Phthalate (DEHP)-Induced Metabolic Disruption: Integrating Gut Hormone Secretion and Metabolomics in Colonic Organoids;Environmental Science & Technology Letters;2024-08-22

5. Incretin-based therapy: a new horizon in diabetes management;Journal of Diabetes & Metabolic Disorders;2024-08-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3